Sony Ericsson's Xperia X1 gets handled, photographed
Filed under: CellphonesThe lucky chaps over at Boy Genius Report have managed to get their hands all over Sony Ericsson's latest and greatest -- the hotly anticipated Xperia X1. Early word is that the 800 x 480 screen, optical joystick, and speedy HSDPA data are all very welcome, but the keyboard (w
An Energy Monitoring Brain Makes This Building the World’s First Zero Carbon Convention Center
It's not often (ever?) that a convention center is anything worth being excited about, but Ireland's new Convention Centre Dublin uses ingenius engineering and an omniscient mother brain to monitor and adjust itself. The result? Zero carbon footprint. Every aspect of the CCD's design has been f
Volkswagen Shows Us Cars From the Future
Volkswagen thinks they know what cars from 2028 will looks like (which is probably fair, since they can basically make the whole thing one big self-fulfilling prophecy). Still, it's exciting to see the designs. The one pictured here is Ego. It's a sporty two-seater without a front window (no, not
GenShocks Shock Absorbers Harness Pothole Energy For Better Fuel Consumption
Potholes, while ruining tires and causing intense levels of irritation, could be put to good use soon, if Levant Power Corporation's plans to develop a shock absorber that harnesses the energy made from potholes' jolts actually go ahead. We first heard of Levant Power Corporation's CEO Shakeel
Cisco Announces Cius 7-Inch HD Android Tablet
Today Cisco has unveiled the Cius, a 7-inch business tablet capable of capturing and displaying high-resolution video among a bevy of other business oriented tasks for which the device is geared. With collaboration and communication portability in mind, the device weighs in at 1.15 pou
Fifteen Visually Stunning Architectural Delights
Those who stay in apartments crave for spacious bungalows and those who live in landscaped acres dread the maintenance! So what really is the ideal size for a home? The multi-storey high-rises offer many titillating features and let’s not even get into their crazy architectural style. Offices,![Nvidia GeForce GTX 200 Graphics Cards Makes Your Gaming Rig Officially Outdated [Nvidia]](http://gizmodo.com/assets/images/gizmodo/2008/06/gtx280.jpg)
Nvidia GeForce GTX 200 Graphics Cards Makes Your Gaming Rig Officially Outdated [Nvidia]
Nvidia's latest line of graphics cards gets official today: The GeForce GTX 260 and GTX 280 mark the debut of the next-gen 200 series, a completely overhauled and badass line of GPUs. The GTX 280 rocks 240 processing cores and 1GB of RAM, while the 260 comes with 192 cores and 896MB of memory, makin![British Farmers to Build Giant, Artificial, 220-Acre Farm Under Glass [Too Much Green]](http://gizmodo.com/assets/images/gizmodo/2008/06/thanetearthabove.jpg)
British Farmers to Build Giant, Artificial, 220-Acre Farm Under Glass [Too Much Green]
Apparently inspired by Buckminster Fuller's push for domed cities, farmers in Kent, England are building a 220-acre series of connected greenhouses, where nothing will be grown in soil. Instead, nutrient-packed water will be used to grow 1.3 million plants hydroponically. The seven greenhouses willFDA Approves Prostate Cancer Vaccine
Posted by AceNik on May 14, 2010•
Email This Post | |
Yesterday, the FDA approved a drug called Provenge. It trains the body’s immune system to fight off advanced prostate cancer. It’s also the first proof we have that immunotherapy works in the fight against the disease.
Provenge from Dendreon isn’t a preventative vaccine; it won’t stave off illness. It is, though, an innovative way to apply traditional vaccine technology to post-diagnosis treatment. It’s an approach with far fewer harsh side-effects than chemotherapy, and in clinical trials it extended the lives of patients by about four months compared to a placebo group.
There are some unfortunate limitations: Provenge has been approved only for a specific subset of “men whose cancer has spread in the body and for whom the hormone-deprivation drugs no longer work but who still have minimal symptoms, or none at all.” Dendreon’s also only been able to produce enough vaccine for 2,000 patients this year, and those who can get Provenge will have to pay out $93,000 for a full three-shot course of treatment.
What’s most important, though, are the broader implications: We know, now, that immunotherapy can work in cancer treatment. It’s only a matter of time before its scope and effectiveness have as broad a reach as the disease itself. [NY Times]
Related posts
Other News:
Loading...
RSS
